search
Back to results

Comparison Between Two Optional IVC Filters Regardind Ease of Use,Complications and Outcome

Primary Purpose

Trauma, Deep Vein Thrombosis

Status
Unknown status
Phase
Not Applicable
Locations
Israel
Study Type
Interventional
Intervention
Optease IVC filters
Gunter-Tulip IVC filters
Sponsored by
Sheba Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Trauma focused on measuring IVC filters, Trauma, Dwell time

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • All patients referred for filter insertion

Exclusion Criteria:

  • Young age (<18 years)

Sites / Locations

  • Sheba medical center

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

1

2

Arm Description

Optease filter

Tulip filter

Outcomes

Primary Outcome Measures

comparing the two filters

Secondary Outcome Measures

Full Information

First Posted
December 25, 2007
Last Updated
January 8, 2008
Sponsor
Sheba Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT00588757
Brief Title
Comparison Between Two Optional IVC Filters Regardind Ease of Use,Complications and Outcome
Official Title
Prospective Comparison Between OptEase and Gunter-Tulip
Study Type
Interventional

2. Study Status

Record Verification Date
December 2007
Overall Recruitment Status
Unknown status
Study Start Date
March 2008 (undefined)
Primary Completion Date
March 2009 (Anticipated)
Study Completion Date
March 2009 (Anticipated)

3. Sponsor/Collaborators

Name of the Sponsor
Sheba Medical Center

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
OptEase filters are easier to retrieve but the dwell time is shorter than the Gunter filters. There are more thrombi on the OptEase than on the Gunter at the time of retrieval. OptEase filter has a better infitration capabillity due to its diamond shape. OptEase filters will hjave more IVC occlusions as a complication.
Detailed Description
We will isert the two filters blindly. We will follow the patients clinically and if needed we will add imaging exams. We will try to retrieve most filters.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Trauma, Deep Vein Thrombosis
Keywords
IVC filters, Trauma, Dwell time

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
100 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
Active Comparator
Arm Description
Optease filter
Arm Title
2
Arm Type
Active Comparator
Arm Description
Tulip filter
Intervention Type
Device
Intervention Name(s)
Optease IVC filters
Intervention Description
IVC filters will be implemented and evaluated for retrieval after 2-3 weeks.
Intervention Type
Device
Intervention Name(s)
Gunter-Tulip IVC filters
Intervention Description
IVC filters will be implemented and evaluated for retrieval after 2-3 weeks.
Primary Outcome Measure Information:
Title
comparing the two filters
Time Frame
1 year

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: All patients referred for filter insertion Exclusion Criteria: Young age (<18 years)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Uri Rimon, MD
Phone
97235302673
Email
rimonu@sheba.health.gov.il
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Uri Rimon, MD
Organizational Affiliation
Sheba Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Sheba medical center
City
Tel hashomer
ZIP/Postal Code
52621
Country
Israel
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Uri Rimon, MD
Phone
97235302673
Email
rimonu@sheba.health.gov.il
First Name & Middle Initial & Last Name & Degree
Uri Rimon, MD

12. IPD Sharing Statement

Learn more about this trial

Comparison Between Two Optional IVC Filters Regardind Ease of Use,Complications and Outcome

We'll reach out to this number within 24 hrs